Position
Creative Planning in Supernus Pharmaceuticals, Inc.
Back to the book · All holders of SUPN
Estimated mark uses implied 13F prices (value ÷ shares). Adds are treated as happening at this quarter’s mark; cuts at last quarter’s. Share jumps can be splits, not buys. This is not realized P&L.
Latest estimated mark $40.3K$49.70 → $51.69
| Quarter | Shares | Value | Implied px | Est. mark | Flow | Weight |
|---|---|---|---|---|---|---|
| Q4 2025 | 20.3K | $1.01M | — | — | — | 0.0% |
| Q1 2026 | 24.3K | $1.25M | $51.69 | $40.3K | $207.3K | 0.0% |